StockTipsArenaBeta

BUY Sai Life Sciences — Shrikant Chouhan, Kotak Securities

BUYSai Life Sciences
Sai Life Sciences share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: NA (inferred 1–3 months)29 Oct 2026via CNBC Awaaz.

Entry₹1,490.8Inferred
Target₹1,600
Total upside +7.32%
Stop loss₹1,460-2.07% risk
CMP₹1,490.2Just now
Active-0.04%+7.37%upside left 3 mo left
Follow Shrikant Chouhan for new calls(42% target hit, 26 closed calls)Get alertsWatch SAILIFE for new buy/sell callsGet alertsSee 1 other Short-term call on SAILIFESee 65 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 12:55 pm IST
5 supporting1 neutral1 opposing
Supports the BUY call (5)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·29 Oct · today

Sai Life Sciences Gets 'Buy' Rating As PL Capital Initiates Coverage; Check Target Price

NewsNdtv-Profit·22 Oct · 1w ago

(opens in new tab)

Buy Sai Life Sciences; target of Rs 1620: Prabhudas Lilladher

NewsGoogle News·21 Oct · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·6 Oct · 3w ago

This multibagger pharma stock is down 10% from record high—CFO reveals growth plan

NewsCnbc-Tv18·30 Sept · 4w ago

(opens in new tab)
Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 05 Nov 2026

BSE · Board Meeting·In 7 days

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·29 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sai Life Sciences

All analyst calls on Sai Life Sciences

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome